Literature DB >> 8990665

Guidelines for the management of Helicobacter pylori-related upper gastrointestinal diseases. Irish Helicobacter Pylori Study Group.

M Buckley1, A Culhane, B Drumm, C Keane, A P Moran, H J O'Connor, J Collins, D Kelleher, D McAvinchey, J Sloan, C O'Morain.   

Abstract

The discovery of H. pylori is the most important development in gastroduodenal disease this century. It has completely changed our understanding of conditions that occur in the upper gastrointestinal tract. Eradication of the bacterium will cure peptic ulcer disease, decrease the symptoms of non-ulcer dyspepsia and may prevent gastric cancer. There has been an exponential increase in the amount of research in this area in recent years and, consequently, there is considerable confusion as to how H. pylori-related conditions should be managed. It is hoped that these guidelines will clarify some of these issues.

Entities:  

Mesh:

Year:  1996        PMID: 8990665

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  2 in total

1.  Detection and identification of Helicobacter pylori directly from gastric biopsies using polymerase chain reaction.

Authors:  K A Ryan; A P Moran; C L Little; M Glennon; T Smith; M Maher
Journal:  Ir J Med Sci       Date:  2002 Apr-Jun       Impact factor: 1.568

2.  Evaluation of clarithromycin resistance and cagA and vacA genotyping of Helicobacter pylori strains from the west of Ireland using line probe assays.

Authors:  K A Ryan; L J van Doorn; A P Moran; M Glennon; T Smith; M Maher
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.